14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Oct 22, 2021 $8.00 $8.05 $7.99 $8.01 1 297 600
Oct 21, 2021 $8.00 $8.00 $7.97 $7.99 1 025 482
Oct 20, 2021 $8.00 $8.03 $7.95 $7.97 1 734 300
Oct 19, 2021 $8.03 $8.05 $7.82 $8.00 2 739 397
Oct 18, 2021 $8.07 $8.08 $8.00 $8.03 3 770 547
Oct 15, 2021 $8.07 $8.08 $8.06 $8.07 953 700
Oct 14, 2021 $8.07 $8.08 $8.06 $8.07 1 900 300
Oct 13, 2021 $8.06 $8.07 $8.05 $8.07 2 813 000
Oct 12, 2021 $8.05 $8.09 $8.04 $8.08 4 504 984
Oct 11, 2021 $7.93 $8.10 $7.90 $8.07 32 217 048
Oct 08, 2021 $4.51 $4.73 $4.49 $4.61 63 200
Oct 07, 2021 $4.67 $4.71 $4.49 $4.51 82 300
Oct 06, 2021 $4.54 $4.70 $4.48 $4.67 109 432
Oct 05, 2021 $4.66 $4.93 $4.51 $4.55 109 432
Oct 04, 2021 $4.72 $4.76 $4.60 $4.64 70 862
Oct 01, 2021 $4.89 $4.89 $4.69 $4.76 62 159
Sep 30, 2021 $4.90 $4.91 $4.79 $4.91 32 090
Sep 29, 2021 $5.10 $5.15 $4.86 $4.87 62 115
Sep 28, 2021 $5.14 $5.20 $5.01 $5.16 193 789
Sep 27, 2021 $4.84 $5.24 $4.72 $5.18 387 400
Sep 24, 2021 $4.81 $4.96 $4.77 $4.88 72 700
Sep 23, 2021 $4.83 $4.89 $4.74 $4.86 71 300
Sep 22, 2021 $4.90 $4.90 $4.76 $4.78 106 700
Sep 21, 2021 $4.87 $4.97 $4.75 $4.88 168 600
Sep 20, 2021 $4.92 $4.94 $4.67 $4.80 164 400
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT